SCHEMBL24310359

SCHEMBL24310359

CCc1c(Oc2cccc(N3CCN(C)CC3)c2F)nc(NSc2cnn(C)c2)nc1-c1ccccc1CC(C)C

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BRD9 Q9H8M2 5/20 0.34
▸ BRPF1 P55201 2/20 0.34
▸ BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310028 0.90 BRPF1 (0.32) BRD9BRPF1BRD4
SCHEMBL24310478 0.86 BRD4 (0.32) BRD9BRPF1BRD4
SCHEMBL24309865 0.86 EGFR (0.33) BRD9BRPF1BRD4
SCHEMBL29566939 0.85 BRD9 (0.36) BRD9BRPF1BRD4
SCHEMBL24310358 0.85 BRD9 (0.36) BRD9BRPF1BRD4
SCHEMBL24310513 0.82 MEN1 (0.33) BRD9BRPF1BRD4
SCHEMBL24309479 0.82 HTR1A (0.33) BRD9BRPF1BRD4
SCHEMBL24309536 0.82 BRPF1 (0.34) BRD9BRPF1BRD4
SCHEMBL24310089 0.81 DRD2 (0.35) BRD9BRPF1BRD4
SCHEMBL24310615 0.80 MAP4K1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback